» Articles » PMID: 18830244

The Essential Role of the CopN Protein in Chlamydia Pneumoniae Intracellular Growth

Overview
Journal Nature
Specialty Science
Date 2008 Oct 3
PMID 18830244
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Bacterial virulence determinants can be identified, according to the molecular Koch's postulates, if inactivation of a gene associated with a suspected virulence trait results in a loss in pathogenicity. This approach is commonly used with genetically tractable organisms. However, the current lack of tools for targeted gene disruptions in obligate intracellular microbial pathogens seriously hampers the identification of their virulence factors. Here we demonstrate an approach to studying potential virulence factors of genetically intractable organisms, such as Chlamydia. Heterologous expression of Chlamydia pneumoniae CopN in yeast and mammalian cells resulted in a cell cycle arrest, presumably owing to alterations in the microtubule cytoskeleton. A screen of a small molecule library identified two compounds that alleviated CopN-induced growth inhibition in yeast. These compounds interfered with C. pneumoniae replication in mammalian cells, presumably by 'knocking out' CopN function, revealing an essential role of CopN in the support of C. pneumoniae growth during infection. This work demonstrates the role of a specific chlamydial protein in virulence. The chemical biology approach described here can be used to identify virulence factors, and the reverse chemical genetic strategy can result in the identification of lead compounds for the development of novel therapeutics.

Citing Articles

Unravelling bacterial virulence factors in yeast: From identification to the elucidation of their mechanisms of action.

Wong Z, Ong E Arch Microbiol. 2024; 206(7):303.

PMID: 38878203 DOI: 10.1007/s00203-024-04023-2.


Whole Genome Sequencing and Comparative Genomic Analysis of Field Strains Isolated from Poultry in Poland.

Zareba-Marchewka K, Bomba A, Scharf S, Niemczuk K, Schnee C, Szymanska-Czerwinska M Pathogens. 2023; 12(7).

PMID: 37513738 PMC: 10384503. DOI: 10.3390/pathogens12070891.


Type III Secretion in .

Rucks E Microbiol Mol Biol Rev. 2023; 87(3):e0003423.

PMID: 37358451 PMC: 10521360. DOI: 10.1128/mmbr.00034-23.


BopN is a Gatekeeper of the Type III Secretion System.

Navarrete K, Bumba L, Prudnikova T, Malcova I, Allsop T, Sebo P Microbiol Spectr. 2023; 11(3):e0411222.

PMID: 37036369 PMC: 10269732. DOI: 10.1128/spectrum.04112-22.


The Spp. Type III Effector Protein OspB Is a Cysteine Protease.

Wood T, Westervelt K, Yoon J, Eshleman H, Levy R, Burnes H mBio. 2022; 13(3):e0127022.

PMID: 35638611 PMC: 9239218. DOI: 10.1128/mbio.01270-22.


References
1.
Horoschak K, MOULDER J . Division of single host cells after infection with chlamydiae. Infect Immun. 1978; 19(1):281-6. PMC: 414078. DOI: 10.1128/iai.19.1.281-286.1978. View

2.
Shafikhani S, Engel J . Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps. Proc Natl Acad Sci U S A. 2006; 103(42):15605-10. PMC: 1622869. DOI: 10.1073/pnas.0605949103. View

3.
Falkow S . Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis. 1988; 10 Suppl 2:S274-6. DOI: 10.1093/cid/10.supplement_2.s274. View

4.
Mumberg D, Muller R, Funk M . Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene. 1995; 156(1):119-22. DOI: 10.1016/0378-1119(95)00037-7. View

5.
Hackstadt T, Scidmore M, Rockey D . Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A. 1995; 92(11):4877-81. PMC: 41810. DOI: 10.1073/pnas.92.11.4877. View